Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Preaching the benefits of vaccination in an increasingly skeptical world

Children's National Hospital infectious disease experts present during IDWeek2019 October 04, 2019

WASHINGTON – So far this calendar year, 1,243 people scattered around 31 states had confirmed measles, the highest number of measles cases reported in the U.S. since 1992. Given the serious complications that can result from a bout with measles - including hospitalization, pneumonia and encephalitis - there’s a long line of folks waiting to get vaccines, including influenza vaccine.

Right? 
Wrong. 

Fewer than half of adults in the U.S. get an annual flu shot, even though the Centers for Disease Control and Prevention (CDC) recommends it for anyone aged 6 months or older “as the first and most important step” in protecting against getting sick

A panel of public health heavyweights will discuss that disconnect in a plenary session titled “All about vaccines: The individual, the community, the world,” the closing session for IDWeek2019, an annual gathering of infectious disease experts held this year from Oct. 2, 2019 to Oct. 6, 2019 in Washington. Among the speakers, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases; Penny M. Heaton, M.D., CEO of the Bill & Melinda Gates Medical Research Institute; and Peter Jay Hotez, M.D., Ph.D. founding dean of the National School of Tropical Medicine at Baylor College of Medicine.

“The reemergence of these neglected diseases is unfortunate, but unless people have firsthand experience with someone who has suffered a serious complication of a vaccine-preventable disease, they don’t appreciate how important vaccines are,” says Roberta L. DeBiasi, M.D., MS, Chief of the Division of Pediatric Infectious Diseases at Children’s National Hospital and IDWeek 2019 co-chair. 

“In the not-so-distant past, these vaccine-preventable illnesses used to circulate broadly - and they still do now around the world in countries where people don’t have access to vaccines. In countries like the U.S., vaccines are successful at keeping the rate of preventable illnesses low when the majority of people are vaccinated. But when people stop vaccinating, these diseases will recur and have done so with increasing frequency,” Dr. DeBiasi adds.

The jam-packed schedule for IDWeek2019 includes presentations about vaccines and other therapies that are effective against infectious diseases, new research insights about emerging infections and updates about global outbreaks past and present, such as measles and Zika. Children’s National faculty is represented all week, including:

  • Sarah B. Mulkey, M.D., Ph.D., a fetal-neonatal neurologist, will present the results of a study (senior author Roberta L. DeBiasi, M.D., MS) designed to assess the neurodevelopmental outcome of a cohort of Colombian infants exposed to Zika in the womb who appeared normal at birth. Dr. Mulkey’s presentation of the study led by Children’s National is part of a global snapshot of Zika’s impact by presenters who include other infectious disease experts from the CDC, as well as other academic centers. 
  • Drs. Michael Bozzella, a second-year fellow, and Andrea Hahn, an infectious disease specialist, will present research that finds that patients with cystic fibrosis treated with broad-spectrum anaerobic antibiotics had greater and more sustained changes in lung microbiome community compared with people who received narrow-spectrum anaerobic antibiotics. Research teams are closely examining how microbial diversity in the lungs is linked to more aggressive disease.
  • Children’s National pediatrics resident Marisu Rueda will be awarded the Pediatric Infectious Diseases Society Antimicrobial Stewardship Fellowship Award for her resident REACH project working with Rana Hamdy, M.D., MPH, MSCE, an infectious disease specialist, and Lamia Soghier, M.D., medical unit director of the neonatal intensive care unit, on a study evaluating blood culture volume in NICU patients. (Blood culture volume is how much blood is taken from tiny babies to send to the laboratory for testing. The less the better, however there are no clear guidelines. This study was to determine how much blood is needed to get a true result for a blood culture.) 
  • And at a joint meeting dubbed the “Spring Break” for infectious disease gurus, these researchers prove they are not all work, no play with BugBowl, a Jeopardy-style live quiz competition with questions just about infectious diseases. TeamDC is a joint Children’s National/National Institutes of Health team that includes Kevin Lloyd, M.D.; Maria Susana Rueda-Altez, M.D.; Kanal Singh, M.D.; and Alexandra Yonts, M.D.

In addition, Children’s National faculty play instrumental roles in other events during the week, including:

Wednesday, Oct. 2, 2019

“Measles outbreaks 2019 special symposium No. 5” co-moderated by Roberta L. DeBiasi, M.D., MS. 12:15 to 1:30 p.m.

“Challenging cases in pediatric infectious disease: Interactive session No. 1,” featuring Benjamin Hanisch, M.D., as a panelist. 1:30 to 3:15 p.m.

Thursday, Oct. 3, 2019

Transplant infectious diseases: Oral abstract session No. 33,” co-moderated by Benjamin Hanisch, M.D. 10:30 to 11:45 a.m.

Pediatric urgent care providers' approach to antibiotic stewardship: A national survey,” presented by Rana Hamdy, M.D., MPH, MSCE. 12:15 to 1:30 p.m.

“Pediatric bacterial diseases: Oral abstract session No. 85,” co-moderated by Nada Harik, M.D. 1:45 to 3 p.m.

Roberta L. DeBiasi, M.D., MS, co-moderates marquee Caroline B. Hall Lecture, “Antenatal Zika virus exposure.”  6 to 7:30 p.m.

Children’s National pediatrics resident Marisu Rueda will receive the Pediatric Infectious Diseases Society (PIDS) Antimicrobial Stewardship Fellowship Award for her resident REACH project with Rana Hamdy, M.D., MPH, MSCE, and Lamia Soghier, M.D., to evaluate blood culture volume in patients in the neonatal intensive care unit. 5:45 p.m., during the PIDS Business meeting.

Friday, Oct. 4, 2019

Rana Hamdy, M.D., MPH, MSCE, and co-author present “Factors associated with reduced vancomycin susceptibility in pediatric Staphylococcus aureus bacteremia.” 12:15 to 1:30 p.m.

Rana Hamdy, M.D., MPH, MSCE, and co-author present “Effect of discharge antibiotic route on clinical outcomes in children with methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis with bacteremia.”  12:15 to 1:30 p.m.

Rana Hamdy, M.D., MPH, MSCE, and co-authors present “Clinical epidemiology of children with orbital cellulitis.” 12:15 to 1:30 p.m.

Nada Harik, M.D., and a co-author present “Epidemiology, management and outcomes of skin and soft tissue infections in well-appearing infants less than 60 days of age.” 12:15 to 1:30 p.m.

Alexandra Brugler Yonts, Michael Jason Bozzella and Nada Harik, M.D., present: “Multidisciplinary initiative to increase guideline-concordant antibiotic prescriptions at discharge for hospitalized children with uncomplicated community-acquired pneumonia.” 12:15 to 1:30 p.m.

Wei Li Koay, MBBS, MSc, was selected to co-moderate the “Hot topics in pediatric infectious disease” session, a discussion of the highest-impact academic papers published this year. 1:45 to 3 p.m.

Roberta L. DeBiasi, M.D., MS, co-moderates “Pediatric emerging viral diseases: Oral abstract session No. 193.” 3:15 to 4:30 p.m.Sarah B. Mulkey presents: “Pediatric emerging viral disease session No. 193.” 3:15 p.m. to 3:30 p.m.

Roberta L. DeBiasi, M.D., MS, co-moderates the Stanley A. Plotkin Lecture in Vaccinology, “Immunizing women to protect their infants: The new normal?” 4:45 to 6 p.m.

Saturday, Oct. 5, 2019

Drs. Michael Jason Bozzella and Andrea Hahn present: “Impact of anaerobic antibacterial spectrum on cystic fibrosis lung microbiome diversity and pulmonary function.” 12:15 to 1:30 p.m.

Lauren Powell, D.O., presents: “Estimate of the effectiveness of the influenza vaccine among children from the 2017-2018 season.” 12:15 to 1:30 p.m.

Roberta L. DeBiasi, M.D., MS, co-moderates “Impact of early life microbiome disruptions in the child.” 1:45 to 3 p.m.

Benjamin Hanisch, M.D., co-moderates “Pediatric viral and fungal disease” oral abstract session No. 297. 1:45 to 3 p.m.

TeamDC, Children’s National Hospital/National Institutes of Health team (Kevin Lloyd, M.D.; Maria Susana Rueda-Altez, M.D.; Kanal Singh, M.D.; and Alexandra Yonts, M.D.) competes in IDBugbowl. 5:15 to 6 p.m.

Media contact: Diedtra Henderson | (443) 610-9826 | (202) 476-4500 
 

About Children's National Hospital

Children’s National Hospital, based in Washington, D.C., has served the nation’s children since 1870. Children’s National is the nation’s No. 6 pediatric hospital and, for the third straight year, is ranked No. 1 in newborn care, as well as ranked in all specialties evaluated by U.S. News & World Report. It has been designated two times as a Magnet® hospital, a designation given to hospitals that demonstrate the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C. Metropolitan area, including the Maryland suburbs and Northern Virginia. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is the seventh-highest NIH-funded children’s hospital in the nation. Children’s National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels.

For more information, follow us on Facebook and Twitter.

Latest Tweets

Follow